Video visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More
Texas Medical Center
6701 Fannin St., Ste. 1510.09
Houston, TX 77030
Holly B. Lindsay, MD, MS
Associate Director, Clinical Division (Inpatient), Cancer and Hematology Center
Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
|Baylor College of Medicine||Fellowship||Clinical Pharmacology||2016|
|Baylor College of Medicine||Fellowship||Pediatric Hematology-Oncology||2015|
|Baylor College of Medicine, Graduate School of Biomedical Sciences||Masters||Master of Science, Clinical Investigation||2015|
|Children's Hospital of Los Angeles||Residency||Pediatrics||2012|
|Washington University in St. Louis School of Medicine||Medical School||Doctor of Medicine||2009|
|Pacific Union College||Bachelors||Bachelor of Science, Chemistry||2005|
Dr. Holly Lindsay’s clinical interests lie in the treatment of children with brain tumors, specifically in the treatment of embryonal brain tumors occurring in infants and toddlers such as atypical teratoid rhabdoid tumor and embryonal tumor with multilayer rosettes. She has received specialized graduate level training in clinical research and pharmacology as a part of the nationally recognized Developmental Therapeutics Program at Texas Children’s Cancer and Hematology Center.
Dr. Lindsay is an active member of the Pediatric Brain Tumor Consortium (PBTC) and Central Nervous System section of the Children’s Oncology Group (COG). She is co-chair of the Society for Neuro-Oncology’s Quarterly Pediatric Molecular Tumor Board and Lindsay currently serves as the American Academy of Pediatrics (AAP) Section on Early Career Physicians’ Liaison to the Section on Advances in Therapeutics and Technology. Additionally, she serves as vice-chair of Baylor College of Medicines Institutional Research Board #5 and is the associate director of inpatient hematology/oncology for Texas Children’s Cancer and Hematology Center.
Dr. Lindsay completed her internship and residency in pediatric medicine at the Children’s Hospital of Los Angeles before relocating to Houston, TX where she completed Baylor College of Medicine’s Fellowship Program in Pediatric Hematology/Oncology at Texas Children’s Hospital, the pediatric teaching hospital of Baylor College of Medicine, and Fellowship Program in Clinical Pharmacology. She additionally earned a Masters degree in Clinical Investigation through the Baylor College of Medicine Graduate School of Biomedical Sciences’ Clinical Scientist Training Program. Her medical degree was awarded by Washington University, St. Louis School of Medicine. Prior to her medical training, she earned her Bachelor of Science in Chemistry and with an emphasis on Biochemistry and graduated Suma Cum Laude with Honors from Pacific Union College. She enjoys being on the board of the directors for the Down Syndrome Association of Houston.
American Board of Pediatrics
American Board of Clinical Pharmacology
|American Academy of Pediatrics (AAP)||Member|
|American Society of Pediatric Hematology/Oncology (ASPHO)||Member|
|Children’s Oncology Group (COG)||Member|
|Pediatric Brain Tumor Consortium (PBTC)||Member|
|Society for Neuro-Oncology (SNO)||Member|
Dr. Holly Lindsay conducted research in the translational neuro-oncology laboratory of Xiao Nan-Li, MD, PhD using his animal models of childhood brain tumors to test new therapies and rapidly bring them to the clinic.
2021 Early Career Faculty Award for Excellence in Patient Care, Baylor College of Medicine
2021 Norton Rose Fulbright Faculty Excellence Award in Teaching and Evaluation, Baylor College of Medicine
2019 Faculty Recognition Award for excellence in teaching, Texas Children’s Cancer and Hematology Center
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.